Author: Reuters

By Ludwig Burger FRANKFURT (Reuters) – German drugmakers have been asked by the government to examine their supply chains for any vulnerability that could cause shortages of essential drugs in the event that Britain leaves...

By John Miller ZURICH (Reuters) – Novartis’ eye care unit Alcon is withdrawing a surgical stent for glaucoma patients after clinical data showed it may damage the eye, but the Swiss drugmaker said the move would not...

By Carolyn Crist (Reuters Health) – Patients undergoing major cancer surgery might reduce their risk of complications by seeing a dentist beforehand, a study from Japan suggests. Patients who visited a dentist were...

By Joshua Franklin and Carl O’Donnell (Reuters) – Sotera Health, a private-equity owned company that operates facilities that sterilize medical products and food, is exploring a potential sale worth as much as $5...

By Gene Emery (Reuters Health) – A new large study of fish oil and aspirin in people with diabetes has found that the oil supplements don’t prevent first-time heart attacks or strokes, yet aspirin does, although the...

By Linda Carroll (Reuters Health) – Nearly one in five American children use at least one prescription medication, and roughly one in 13 kids takes more than one prescription drug, according to a new study. And among the...

BRAZZAVILLE (Reuters) – Congo Republic has confirmed a case of yellow fever near the border with an Angolan enclave, the health ministry said on Tuesday, and has warned of “an emerging event of epidemic...

By Ben Hirschler LONDON (Reuters) – A cutting-edge CAR-T cell therapy for otherwise untreatable forms of blood cancer is too expensive to justify its use on Britain’s state-funded health service, the country’s...